What are the Historical Developments and Current Growth Metrics of the Urinary Tract Obstruction Treatment Devices Market?
The urinary tract obstruction treatment devices market has seen considerable growth due to a variety of factors.
• Despite recent sturdy growth in the size of the urinary tract obstruction (UTO) treatment devices market, its upward trajectory is poised to continue, soaring from $1.32 billion in 2024 to $1.41 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.6%.
Factors contributing to the market's growth during the historical period include a higher incidence of urological disorders, rising demand for sophisticated treatment approaches, wider acceptance of minimally invasive procedures, escalating need for advanced catheter and stent technologies, and an increasing emphasis on surgeries assisted by robotics.
What is the Forecasted Market Size and CAGR for the Urinary Tract Obstruction Treatment Devices Market?
The urinary tract obstruction treatment devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a significant surge is anticipated in the market size of urinary tract obstruction (UTO) treatment devices. The projection suggests growth to $1.80 billion by 2029, subject to a compound annual growth rate (CAGR) of 6.4%.
This expansion during the forecasted time is ascribed to the escalating prevalence of urological disorders, a burgeoning demand for customized treatment solutions, increased acceptance of robot-aided surgeries, and improved health awareness among patients. Major developments forecasted for this period include advancements in minimally invasive procedures, creation of more effective and less discomforting treatment methods, groundbreaking innovations in materials, and incorporation of enhanced imaging and diagnostic instruments.
What Are the Critical Driver Fuelling the Urinary Tract Obstruction Treatment Devices Market's Growth?
The escalating incidence of kidney disease is predicted to catalyze the expansion of the urinary tract obstruction treatment devices market. This disease is characterized by the impairment or harm to the kidneys, impacting their capacity to sift waste and surplus fluids out of the bloodstream. Aging populations, escalating instances of diabetes and hypertension, and unwholesome lifestyles are some factors that contribute to the rising prevalence of kidney disease. Medical intervention is necessary to alleviate strain on the kidneys and maintain renal functionality. As the ailment advances, urinary tract blockages become more prevalent necessitating the use of devices to control and deter further damage to the kidneys. For example, a report published by Kidney Research UK, a non-profit organization based in the UK, stated in June 2023 that around 7.2 million people in the UK, accounting for over 10% of the population, are currently living with chronic kidney disease. Of these, 3.25 million are in the terminal stages of the disease while a further 3.9 million are in the initial stages. The number of people afflicted with chronic kidney disease is forecasted to jump to 7.61 million by 2033. As such, the growing incidence of kidney disease is anticipated to fuel the expansion of the urinary tract obstruction treatment devices market.
What Are The Principal Market Segments In The Global Urinary Tract Obstruction Treatment Devices Healthcare Industry?
The urinary tract obstruction treatment devices market covered in this report is segmented –
1) By Type: Urinary Catheter, Ureteroscope, Shock Wave Lithotripters, Laser Therapy Systems, Other Types
2) By Application: Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis
3) By End-User: Hospitals, Ambulatory Surgical Centers, Surgical Centers, Other End-Users
Subsegments:
1) By Urinary Catheter: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters, Hydrophilic-Coated Urinary Catheters
2) By Ureteroscope: Rigid Ureteroscopes, Flexible Ureteroscopes, Semi-Rigid Ureteroscopes, Digital Ureteroscopes
3) By Shock Wave Lithotripters: Extracorporeal Shock Wave Lithotripters (ESWL), Pneumatic Shock Wave Lithotripters, Electrohydraulic Shock Wave Lithotripters, Laser-Assisted Shock Wave Lithotripters
4) By Laser Therapy Systems: Holmium Laser Therapy Systems, Thulium Laser Therapy Systems, Diode Laser Therapy Systems, Nd: YAG Laser Therapy Systems
5) By Other Types: Stents For Urinary Tract Obstruction, Percutaneous Nephrostomy Devices, Ureteral Balloon Dilation Catheters, Ureteral Access Sheaths, Urological Drainage Devices
Pre-Book The Urinary Tract Obstruction Treatment Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Urinary Tract Obstruction Treatment Devices Market?
Leading businesses in the urinary tract obstruction treatment devices market are concentrating on crafting innovative products like intermittent urological catheters that offer enduring solutions for handling urinary tract blockages. Intermittent urological catheters serve to drain urine temporarily from patients' bladders who can't urinate naturally, thereby preventing urinary tract infections, bladder damage, and kidney issues through regular bladder emptying. For instance, the Japan-based pharmaceutical company Otsuka Pharmaceutical Factory, Inc. launched the OT-Balloon Catheter in August 2022. This revolutionary, reusable catheter is specifically crafted for individuals struggling with spontaneous urination. By inflating a balloon at its edge, it temporarily stays in the bladder, allowing self-catheterization, and lessening the need for constant reapplication. This product underlines Otsuka's ongoing pledge to improve patient care by providing solutions that encourage more autonomy in managing excretion.
Who Are the Key Players in the Urinary Tract Obstruction Treatment Devices Market?
Major companies operating in the urinary tract obstruction treatment devices market are include:
• Medtronic Plc
• Becton Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Coloplast Corporation
• Smiths Group plc
• Bio-Rad Laboratories
• Teleflex Incorporated
• Paul Hartmann AG
• Karl Storz SE & Co. KG
• Cook Medical
• Hollister Incorporated
• Amsino International Inc.
• Richard Wolf GmbH
• Braun Melsungen AG
• Angiplast Pvt. Ltd.
• Mais India Medical Devices Pvt. Ltd.
• Convatec Inc.
• VYGON (UK) LTD.
• United Endoscopy
• Advin Health Care
• Manish Medi Innovation
• MicroPort Urocare (Jiaxing) Co. Ltd.
• Nikotech Pvt Ltd.
What are the Regional Insights into the Urinary Tract Obstruction Treatment Devices Market?
North America was the largest region in the urinary tract obstruction treatment devices market in 2024. The regions covered in the urinary tract obstruction treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
